Clinical Chemistry

In Other News

• Routine Blood Tests Years Before Pregnancy Could Identify Preeclampsia Risk

• Blood Test Detects Testicular Cancer Missed by Standard Markers

• Routine Blood Tests Identify Biomarkers Linked to PTSD

• Proteomic Data Underscore Need for Age-Specific Pediatric Reference Ranges

• Routine Blood Count Ratio Linked to Future Alzheimer’s and Dementia Risk

• Label-Free Microfluidic Device Enriches Tumor Cells and Clusters from Pleural Effusions

• Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

• Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

• Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

• Study Finds ApoB Testing More Effective Than LDL for Guiding Lipid Therapy

• AI-Enabled POC Test Quantifies Multiple Cardiac Biomarkers

• Next Generation Automated Analyzers Increase Throughput for Clinical Chemistry and Electrolyte Testing

• Blood Metabolite Test Detects Early Cognitive Decline

• AI-Based Blood Test Diagnose Multiple Brain Disorders from Blood Sample

• Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection

• Rapid Biosensor Detects Drug Sensitivity in Breast Tumors

• New CLIA Status Brings Mass Spectrometry Steroid Testing to Routine Labs

• Study Shows Dual Biomarkers Improve Accuracy of Alzheimer’s Detection

• Blood-Based Screening Test Targets Early Detection of Colorectal Cancer

• Automated NfL Assay Supports Monitoring of Neurological Disorders

• CSF Biomarker Improves Diagnosis of Parkinson’s Disease and Lewy Body Dementia

• Simple Urine Home Test Kit Could Detect Early-Stage Breast Cancer

• New Tool Tracks Biomarker Changes to Predict Myeloma Progression